Sartorius Stedim Biotech SA - Asset Resilience Ratio
Sartorius Stedim Biotech SA (DIM) has an Asset Resilience Ratio of 0.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check DIM capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Sartorius Stedim Biotech SA's Asset Resilience Ratio has changed over time. See how leveraged is Sartorius Stedim Biotech SA's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Sartorius Stedim Biotech SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Sartorius Stedim Biotech SA.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.20 Million | 0.32% |
| Total Liquid Assets | €26.20 Million | 0.32% |
Asset Resilience Insights
- Limited Liquidity: Sartorius Stedim Biotech SA maintains only 0.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sartorius Stedim Biotech SA Industry Peers by Asset Resilience Ratio
Compare Sartorius Stedim Biotech SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.74% |
|
IVF Hartmann Holding AG
SW:VBSN |
Medical Instruments & Supplies | 52.05% |
|
Dentium
KO:145720 |
Medical Instruments & Supplies | 1.23% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
DIO Corporation
KQ:039840 |
Medical Instruments & Supplies | 8.52% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for Sartorius Stedim Biotech SA (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Sartorius Stedim Biotech SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.10% | €8.10 Million ≈ $9.47 Million |
€8.02 Billion ≈ $9.37 Billion |
-0.02pp |
| 2024-12-31 | 0.12% | €9.90 Million ≈ $11.57 Million |
€8.26 Billion ≈ $9.65 Billion |
0.00pp |
| 2023-12-31 | 0.12% | €9.50 Million ≈ $11.11 Million |
€7.74 Billion ≈ $9.05 Billion |
-0.39pp |
| 2022-12-31 | 0.51% | €25.90 Million ≈ $30.28 Million |
€5.07 Billion ≈ $5.92 Billion |
+0.16pp |
| 2021-12-31 | 0.35% | €13.72 Million ≈ $16.04 Million |
€3.95 Billion ≈ $4.62 Billion |
+0.03pp |
| 2020-12-31 | 0.32% | €9.84 Million ≈ $11.51 Million |
€3.07 Billion ≈ $3.59 Billion |
-0.68pp |
| 2019-12-31 | 1.01% | €18.30 Million ≈ $21.39 Million |
€1.82 Billion ≈ $2.13 Billion |
-0.22pp |
| 2018-12-31 | 1.22% | €19.21 Million ≈ $22.46 Million |
€1.57 Billion ≈ $1.84 Billion |
+0.31pp |
| 2017-12-31 | 0.91% | €12.84 Million ≈ $15.01 Million |
€1.40 Billion ≈ $1.64 Billion |
+0.22pp |
| 2016-12-31 | 0.69% | €8.27 Million ≈ $9.66 Million |
€1.20 Billion ≈ $1.40 Billion |
-0.09pp |
| 2015-12-31 | 0.78% | €8.35 Million ≈ $9.76 Million |
€1.07 Billion ≈ $1.25 Billion |
+0.03pp |
| 2014-12-31 | 0.75% | €6.79 Million ≈ $7.94 Million |
€906.76 Million ≈ $1.06 Billion |
-0.02pp |
| 2013-12-31 | 0.77% | €6.70 Million ≈ $7.83 Million |
€871.23 Million ≈ $1.02 Billion |
+0.90pp |
| 2012-12-31 | -0.13% | €-1.05 Million ≈ $-1.23 Million |
€793.87 Million ≈ $928.11 Million |
+0.13pp |
| 2008-12-31 | -0.26% | €-1.69 Million ≈ $-1.98 Million |
€652.34 Million ≈ $762.66 Million |
-- |
About Sartorius Stedim Biotech SA
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more